Childhood Maltreatment and Telomere Shortening: Preliminary Support for an Effect of Early Stress on Cellular Aging
Background
Psychological stress and trauma are risk factors for several medical and psychiatric illnesses. Recent studies have implicated advanced cellular aging as a potential mechanism of this association. Telomeres, DNA repeats that cap the ends of chromosomes and promote stability, shorten progressively with each cell division; their length is a marker of biological aging. Based on previous evidence linking psychosocial stress to shorter telomere length, this study was designed to evaluate the effect of childhood adversity on telomere length.
Methods
Thirty-one adults with no current or past major Axis I psychiatric disorder participated. Subjects reported on their history of childhood maltreatment and telomere length was measured from DNA extracted from frozen whole blood using quantitative polymerase chain reaction.
Results
Participants reporting a history of childhood maltreatment had significantly shorter telomeres than those who did not report a history of maltreatment. This finding was not due to effects of age, sex, smoking, body mass index, or other demographic factors. Analysis of subscales showed that both physical neglect and emotional neglect were significantly linked to telomere length.
Conclusions
These results extend previous reports linking shortened leukocyte telomere length and caregiver stress to more remote stressful experiences in childhood and suggest that childhood maltreatment could influence cellular aging.
Similar entries
- Symmetric faces are a sign of successful cognitive aging
- Continuous Deep Sedation in Medical Practice: A Descriptive Study
- Medication beliefs predict medication adherence in older adults with multiple illnesses
- Increased telomerase activity and comprehensive lifestyle changes: a pilot study
- The Association of Smoking and Alcohol Use With Age-related Macular Degeneration in the Oldest Old
- PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab...
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin)...
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- The ageing brain
- Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study



